|
CN103992310B
(zh)
*
|
2013-05-14 |
2016-07-06 |
中国医学科学院医药生物技术研究所 |
一组取代苯并杂环胺衍生物及其制备方法和作为impdh抑制剂的相关应用
|
|
CN104102839B
(zh)
*
|
2013-11-16 |
2017-10-27 |
西安电子科技大学 |
一种基于多尺度网格曲面形状特征的阿尔茨海默病脑皮层自动分类方法
|
|
CN104672208B
(zh)
*
|
2013-11-27 |
2017-01-04 |
中国科学院大连化学物理研究所 |
一种（3,5-双三氟甲基吡唑基)吡啶衍生物的合成方法
|
|
CN103626767A
(zh)
*
|
2013-12-04 |
2014-03-12 |
上海药明康德新药开发有限公司 |
区域选择性的氮杂吲哚及其合成方法
|
|
WO2015110263A1
(en)
|
2014-01-21 |
2015-07-30 |
Ac Immune Sa |
Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyolid-like proteins
|
|
US9732103B2
(en)
|
2014-02-25 |
2017-08-15 |
Achillion Pharmaceuticals, Inc. |
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
|
|
WO2015138273A1
(en)
*
|
2014-03-13 |
2015-09-17 |
Merck Sharp & Dohme Corp. |
2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
|
|
RU2017107558A
(ru)
|
2014-09-15 |
2018-10-18 |
Руджен Холдингс (Кайман) Лимитед |
Производные пирролопиримидина в качестве антагонистов nmda-рецептора nr2b
|
|
US10221182B2
(en)
|
2015-02-04 |
2019-03-05 |
Rugen Holdings (Cayman) Limited |
3,3-difluoro-piperidine derivatives as NR2B NMDA receptor antagonists
|
|
KR102613179B1
(ko)
*
|
2015-06-01 |
2023-12-14 |
뤼겐 홀딩스 (케이맨) 리미티드 |
Nr2b nmda 수용체 길항제로서의 3,3-디플루오로피페리딘 카바메이트 헤테로사이클릭 화합물
|
|
WO2017035361A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Disubstituted compounds for the treatment of medical disorders
|
|
WO2017035401A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Amide compounds for treatment of immune and inflammatory disorders
|
|
AR105809A1
(es)
|
2015-08-26 |
2017-11-08 |
Achillion Pharmaceuticals Inc |
Compuestos para el tratamiento de trastornos médicos
|
|
AR106018A1
(es)
|
2015-08-26 |
2017-12-06 |
Achillion Pharmaceuticals Inc |
Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
|
|
WO2017035409A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
|
|
WO2017035357A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Phosphonate compounds for treatment of medical disorders
|
|
WO2017035408A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Compounds for treatment of immune and inflammatory disorders
|
|
WO2017035405A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Amino compounds for treatment of immune and inflammatory disorders
|
|
AR105808A1
(es)
|
2015-08-26 |
2017-11-08 |
Achillion Pharmaceuticals Inc |
Compuestos de amida para el tratamiento de trastornos médicos
|
|
US10385097B2
(en)
|
2015-08-26 |
2019-08-20 |
Achillion Pharmaceuticals, Inc. |
Ether compounds for treatment of medical disorders
|
|
WO2017035351A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Amino compounds for treatment of medical disorders
|
|
EP3374381A4
(en)
|
2015-11-09 |
2019-05-15 |
The University Of British Columbia |
EPITOPES IN THE AMYLOID-BETA MEDIUM REGION AND CONFORMITY-SELECTIVE ANTIBODIES THEREOF
|
|
KR102776187B1
(ko)
|
2015-11-09 |
2025-03-07 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
아밀로이드 베타에서의 n-말단 에피토프 및 이에 형태적으로-선택적인 항체
|
|
AU2016353553B2
(en)
|
2015-11-09 |
2022-01-20 |
The University Of British Columbia |
Amyloid beta epitopes and antibodies thereto
|
|
US10300155B2
(en)
|
2015-12-31 |
2019-05-28 |
Washington University |
Alpha-synuclein ligands
|
|
BR112018068066B1
(pt)
|
2016-03-11 |
2023-11-28 |
Ac Immune Sa |
Compostos bicíclicos e seu uso, composição diagnóstica e farmacêutica, misturas, métodos de coleção de dados para diagnóstico, para determinar uma predisposição a, para monitorar transtorno residual e para prever a capacidade de resposta de um paciente sofrendo de transtorno ou anormalidade associado com agregados de alfa-sinucleína, métodos para determinar a quantidade de agregados de alfa-sinucleína e para preparar um composto, kit teste e kit para preparar uma preparação radio farmacêutica
|
|
AU2017295863B2
(en)
|
2016-07-13 |
2022-07-07 |
Medic Life Sciences, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
|
CN109476729A
(zh)
|
2016-07-18 |
2019-03-15 |
英属哥伦比亚大学 |
淀粉样蛋白β的抗体
|
|
WO2018067662A1
(en)
*
|
2016-10-04 |
2018-04-12 |
University Of Miami |
Protein amyloidogenesis and related methods
|
|
US20180125920A1
(en)
|
2016-11-09 |
2018-05-10 |
The University Of British Columbia |
Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
|
|
US11000526B2
(en)
|
2016-11-22 |
2021-05-11 |
Rugen Holdings (Cayman) Limited |
Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders
|
|
EP3589287B1
(en)
|
2017-03-01 |
2022-09-14 |
Achillion Pharmaceuticals, Inc. |
Macrocyclic compounds for treatment of medical disorders
|
|
WO2018160891A1
(en)
|
2017-03-01 |
2018-09-07 |
Achillion Pharmaceutical, Inc. |
Pharmaceutical compounds for treatment of medical disorders
|
|
CN110603252A
(zh)
|
2017-03-01 |
2019-12-20 |
艾其林医药公司 |
用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
|
|
RU2678987C2
(ru)
*
|
2017-04-28 |
2019-02-05 |
Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" |
Пептид для лечения болезни альцгеймера
|
|
ES2984844T3
(es)
|
2017-07-18 |
2024-10-31 |
Univ British Columbia |
Anticuerpos contra beta amiloide
|
|
US12286469B2
(en)
|
2017-07-18 |
2025-04-29 |
The University Of British Columbia |
Humanized antibodies binding to amyloid-beta (A-beta)
|
|
EP3661493A4
(en)
|
2017-08-02 |
2021-04-14 |
Achillion Pharmaceuticals, Inc. |
THERAPY PLANS FOR TREATMENT OF PAROXYSMALER NIGHTLY HEMOGLOBINURIA
|
|
PE20211090A1
(es)
|
2018-01-05 |
2021-06-14 |
Ac Immune Sa |
Derivados de 1,3,4,5-tetrahidro-2h-pirido[4,3-b]indol para el tratamiento, alivio o prevencion de trastornos asociados con los agregados de tau
|
|
EP3743115A1
(en)
*
|
2018-01-24 |
2020-12-02 |
AC Immune SA |
Diagnostic compositions for pet imaging, a method for manufacturing the diagnostic composition and its use in diagnostics
|
|
CN108558905B
(zh)
*
|
2018-05-21 |
2021-03-12 |
华南农业大学 |
一种噻喃[4,3-b]吲哚类化合物及其制备方法和应用
|
|
CN112313230B
(zh)
*
|
2018-06-04 |
2024-03-15 |
Ac免疫有限公司 |
用于治疗、缓解或预防与Tau聚集体相关的病症的新型化合物
|
|
CN112351984B
(zh)
|
2018-06-04 |
2024-01-02 |
Ac免疫有限公司 |
用于治疗、缓解或预防与Tau聚集物相关病症的四氢苯并呋喃并[2.3-c]吡啶和β-咔啉化合物
|
|
EA202091395A1
(ru)
*
|
2018-06-04 |
2020-10-01 |
Ас Иммьюн Са |
ПРОИЗВОДНЫЕ 1,3,4,5-ТЕТРАГИДРО-2Н-ПИРИДО[4,3-b]ИНДОЛА ДЛЯ ЛЕЧЕНИЯ, ОБЛЕГЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ РАССТРОЙСТВ, СВЯЗАННЫХ С АГРЕГАТАМИ ТАУ, ТАКИХ КАК БОЛЕЗНЬ АЛЬЦГЕЙМЕРА
|
|
WO2019234243A1
(en)
|
2018-06-08 |
2019-12-12 |
Ac Immune Sa |
Novel compounds for diagnosis
|
|
WO2020025066A1
(en)
*
|
2018-08-03 |
2020-02-06 |
The University Of Hong Kong |
Compositions and methods for detection and imaging of amyloid fibrils, amyloid plaques, rna, and nucleoli
|
|
WO2020051538A1
(en)
|
2018-09-06 |
2020-03-12 |
Achillion Pharmaceuticals, Inc. |
Morphic forms of complement factor d inhibitors
|
|
JP7443375B2
(ja)
|
2018-09-06 |
2024-03-05 |
アキリオン ファーマシューティカルズ， インコーポレーテッド |
医学的障害の治療のための大環状化合物
|
|
KR20210093855A
(ko)
|
2018-09-25 |
2021-07-28 |
아칠리온 파르마세우티칼스 인코포레이티드 |
보체 인자 d 억제제의 형태체 형태
|
|
CA3118692A1
(en)
|
2018-11-06 |
2020-05-14 |
Alsatech, Inc. |
Cell-based gene therapy for neurodegenerative diseases
|
|
WO2020131974A1
(en)
|
2018-12-17 |
2020-06-25 |
Achillion Pharmaceuticals, Inc. |
Targeted dosing for the treatment of complement mediated disorders
|
|
JP7232931B2
(ja)
*
|
2019-03-01 |
2023-03-03 |
エイシー イミューン ソシエテ アノニム |
タウ凝集体に関連する障害の治療、緩和、または予防のための新規化合物
|
|
BR112021018456A2
(pt)
|
2019-03-22 |
2021-11-23 |
Achillion Pharmaceuticals Inc |
Compostos farmacêuticos para o tratamento de distúrbios mediados por complemento
|
|
WO2020247707A1
(en)
*
|
2019-06-05 |
2020-12-10 |
Chunyu Wang |
SYSTEMS AND METHOD FOR INHIBITING γ-SECRETASE PRODUCTION OF AMYLOID-β PEPTIDES
|
|
US12297244B2
(en)
|
2019-06-05 |
2025-05-13 |
Rensselaer Polytechnic Institute |
Systems and methods for inhibiting γ-secretase production of amyloid-β peptides
|
|
CN110964035A
(zh)
*
|
2019-12-06 |
2020-04-07 |
北大医药股份有限公司 |
一种将奥氮平母液进行清洁回收的工业化方法
|
|
KR20230008183A
(ko)
|
2020-05-07 |
2023-01-13 |
에이씨 이뮨 에스에이 |
진단을 위한 신규한 화합물
|
|
KR20230066311A
(ko)
*
|
2020-06-10 |
2023-05-15 |
델릭스 테라퓨틱스, 인크. |
삼환형 사이코플라스토겐 및 이의 용도
|
|
CA3195695A1
(en)
|
2020-09-30 |
2022-04-07 |
Astrazeneca Ab |
Compounds and their use in treating cancer
|
|
US20240327393A1
(en)
*
|
2021-07-09 |
2024-10-03 |
Sironax Ltd. |
Ferroptosis modulators, preparations, and uses thereof
|
|
WO2023023474A1
(en)
*
|
2021-08-16 |
2023-02-23 |
Senya Pharmaceuticals, Inc. |
Tr-beta modulators, pharmaceutical compositions, and therapeutic applications
|
|
EP4430044A1
(en)
|
2021-11-10 |
2024-09-18 |
AC Immune SA |
Dihydropyrrolo[3,4-c]pyrazole derivatives and their use in diagnosis
|
|
CN118215667A
(zh)
|
2021-11-10 |
2024-06-18 |
Ac免疫有限公司 |
用于诊断的4h-咪唑并[1,5-b]吡唑衍生物
|
|
AU2022387830A1
(en)
|
2021-11-10 |
2024-05-23 |
Ac Immune Sa |
Dihydropyrrolo[3,4c]-pyrazole derivatives and their use in diagnosis
|
|
IL313455A
(en)
|
2021-12-15 |
2024-08-01 |
Delix Therapeutics Inc |
Phenoxy and benzyloxy modified psychroplastogens and their uses
|
|
EP4558138A2
(en)
*
|
2022-07-21 |
2025-05-28 |
Flexsys America L.P. |
Aminoindole antidegradant compounds and uses thereof
|
|
CN120344535A
(zh)
|
2022-12-16 |
2025-07-18 |
Ac免疫有限公司 |
用于诊断的新化合物
|
|
JP2026500311A
(ja)
|
2022-12-16 |
2026-01-06 |
エーシー・イミューン・エス・アー |
診断のための新規化合物
|
|
WO2024220996A2
(en)
*
|
2023-04-21 |
2024-10-24 |
Stowers Institute For Medical Research |
Methods for diagnosing, screening and treating an amyloid-associated condition
|
|
CN121175305A
(zh)
|
2023-05-15 |
2025-12-19 |
Ac免疫有限公司 |
用于治疗与α-突触核蛋白聚集相关的疾病的新型化合物
|
|
US20250022550A1
(en)
*
|
2023-07-11 |
2025-01-16 |
Karl Thompson |
Systems and methods for predicting pet amyloid biomarker status using multimodal digital cognitive assessments
|
|
WO2025037013A1
(en)
|
2023-08-16 |
2025-02-20 |
Ac Immune Sa |
Diagnostic compounds that bind to alpha-synuclein
|